Revenue
14.8 million USD
2026 · USD
Exact inputs and evidence
- Revenue: 14822799 USD Source
Annual consolidated revenue for 2026: about USD 14.82M, using the latest reported figures. The previous period, 2025, was about USD 7.016M.
2693586 USD
1500 shares
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-30.
Financial data available through: 2026-06-30.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 7.02 million
–
Current period
USD 14.82 million
–
14822799 − 7015512 = 7807287 USD
7015512 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source14822799 USD · 2025-07-01 – 2026-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 7.66 million
–
Current period
−USD 12.16 million
–
-12162391 − -7659667 = -4502724 USD
-7659667 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source-12162391 USD · 2025-07-01 – 2026-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 1.01 million
–
Current period
−USD 2.75 million
–
-2754624 − -1010799 = -1743825 USD
-1010799 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source-2754624 USD · 2025-07-01 – 2026-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2025 2024-07-01 – 2025-06-30 | 7015512 | 10060358 Derived | -3044846 | 4614821 Derived | -7659667 | -1012937 Derived | Source
|
| 2026 2025-07-01 – 2026-06-30 | 14822799 | 19623639 Derived | -4800840 | 7361551 Derived | -12162391 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2025 | Revenue | 7015512 |
|
| 2026 | Revenue | 14822799 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Year over year | No prior comparable period |
|
| 2026 | Year over year | 111.3% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Operating margin | -43.4% |
|
| 2026 | Operating margin | -32.4% |
|
| 2025 | Net margin | -109.2% |
|
| 2026 | Net margin | -82.1% |
|
| 2025 | Free cash flow margin | -14.4% |
|
| 2026 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2025 | Operating cash flow | -1010799 |
|
| 2026 | Operating cash flow | -2754624 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2025 | Free cash flow | -1012937 |
|
| 2026 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Liabilities / assets | 277.5% |
|
| 2026 | Liabilities / assets | 474% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Current assets / current liabilities | 0.36× |
|
| 2026 | Current assets / current liabilities | 0.2× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2025 2024-07-01 – 2025-06-30 | −USD 7.66 million Exact valueExact value: -7659667 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.01 million Exact valueExact value: -1010799 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2,138 Exact valueExact value: 2138 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.01 million Calculation and evidence-1010799 − 2138 USD Exact free cash flow: -1012937 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-07-01 – 2026-06-30 | −USD 12.16 million Exact valueExact value: -12162391 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.75 million Exact valueExact value: -2754624 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
5 filings · 93 latest values · 93 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0002109869, 2109869, edgar:2109869
Also known as D. BORAL ARC MERGER CORP, D. Boral ARC Merger Corp, EXASCALE LABS HOLDINGS INC., Exascale Labs Holdings Inc.